Efficacy

The Effects of Dietary Protein on Physical Performance in Older Adults with Type 2 Diabetes Study Overview This study looked at how increasing dietary protein can help older adults with type 2 diabetes. The goal was to see if more protein can improve muscle mass, strength, and physical performance. Study Method In a 12-week study, 26 participants aged 55 and older with type 2 diabetes were divided into two groups: Control Group: Received 0.8-1.0 g/kg/day of protein. Intervention Group: Received 1.2-1.5 g/kg/day of protein. We measured body composition, muscle strength, and other health markers at the start and end of… ➡️➡️➡️

Study Overview This study examines how the location of metastatic sites affects the treatment outcomes of recurrent or metastatic nasopharyngeal carcinoma (R/M NPC) patients receiving a PD-L1 inhibitor called KL-A167. Key Findings Patient Demographics: 153 patients were studied, with an average age of 47 years; 81% were male. Metastatic Sites: Most patients had distant metastasis, with many having more than two sites, including the liver, lung, lymph nodes, and bones. Survival Rates: Patients without liver metastasis had significantly better outcomes: Progress-Free Survival (PFS): 144 days vs. 72 days for those with liver metastasis. Overall Survival (OS): 730 days vs. 305… ➡️➡️➡️

Clinical Manifestations Study Overview This study looked at how well computerized cognitive training (CCT) works when combined with selective serotonin reuptake inhibitors (SSRIs) for patients with late-life depression (LLD). Method The research took place from May 5, 2021, to April 21, 2023. Patients diagnosed with major depressive disorder were divided into two groups: CCT and SSRIs: 57 patients SSRIs and Control: 61 patients They received treatment for up to 12 weeks. The main focus was to see changes in cognitive function, measured by the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog). Results In total, 118 patients were analyzed. Both groups showed… ➡️➡️➡️

Clinical Manifestations Background Cognitive issues affect about 40% of people with heart failure (HF). This study looks at how patients with HF view their cognitive abilities and how these views relate to actual cognitive performance. Method We used initial data from a randomized controlled trial involving 73 HF patients to test a cognitive intervention aimed at improving attention. Data were collected through phone interviews during the COVID-19 pandemic from July 2020 to May 2021. We measured perceived cognitive effectiveness using the Attentional Function Index (AFI), which has 13 questions about attention, working memory, and executive function. Scores range from 0… ➡️➡️➡️

Comparative Immunogenicity of Biosimilar Natalizumab Overview Biosimilar natalizumab (biosim-NTZ) is the first biosimilar version of the original natalizumab (ref-NTZ) used to treat relapsing forms of multiple sclerosis (MS). This study aimed to confirm that biosim-NTZ has a similar immunogenicity profile to ref-NTZ. Study Methods Two key clinical studies were conducted: Efficacy and Safety Study: 264 patients with relapsing-remitting MS received monthly infusions of either biosim-NTZ or EU-ref-NTZ for 48 weeks. The main focus was on the first 24 weeks. Pharmacokinetic/Pharmacodynamic Study: 450 healthy subjects received a single dose of biosim-NTZ, US-ref-NTZ, or EU-ref-NTZ, followed by an 85-day monitoring period. Advanced… ➡️➡️➡️

Zanubrutinib plus R-CHOP for Double-Expressor Lymphoma Study Overview This study focuses on double-expressor lymphoma (DEL), which has a worse outlook than other types of diffuse large B-cell lymphoma (DLBCL). It evaluates the effectiveness and safety of combining zanubrutinib with the R-CHOP treatment (which includes rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) for patients with DEL at stage II or higher. Study Details From November 2020 to July 2022, 48 newly diagnosed patients participated. They received: Twice-daily oral zanubrutinib (160 mg) for 6 months Standard R-CHOP treatment for six to eight cycles Results The results showed: Objective Response Rate (ORR): 89.6% Complete… ➡️➡️➡️

Modulation of Hormonal, Metabolic, and Inflammatory Biomarkers in Women with PCOS Study Overview Polycystic Ovary Syndrome (PCOS) is a common condition among women. Exercise is known to help, but there’s limited research on the best types of exercise. This study looked at how combined training (both resistance and endurance) affects various health markers in women with PCOS. Methodology We conducted a randomized controlled trial with 30 women aged around 24 years, who were divided into two groups. One group participated in a combined training program for eight weeks, while the other group did not. We measured several health indicators before… ➡️➡️➡️

Hydroxychloroquine Improves Health in Obese Women with PCOS Study Overview Hydroxychloroquine (HCQ) is commonly used for immune disorders and shows promise in helping obese women with polycystic ovary syndrome (PCOS) by lowering blood sugar levels. However, how it works is still not fully understood. Study Purpose This study aimed to see how HCQ affects blood sugar, fat levels, and hormone levels in obese women with PCOS. Methodology Fifty obese women with PCOS participated in the study. They were divided into two groups: HCQ Group: 25 women received 200 mg of hydroxychloroquine daily. Metformin Group: 25 women received 1000 mg of… ➡️➡️➡️

Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers Introduction Alcoholic hallucinosis (AH) is a serious issue related to chronic alcoholism, causing symptoms like auditory hallucinations and delusions. Haloperidol is a common treatment, but it often has side effects. By using pharmacogenetic testing, specifically focusing on the CYP2D6 gene, we can customize haloperidol dosages, which leads to safer and more effective treatment. Study Overview We studied 100 men diagnosed with «psychotic disorder induced by alcohol use» and divided them into two groups: Main Group: 45 patients received haloperidol… ➡️➡️➡️

Optical Molecular Imaging in Oral and Oropharyngeal Cancer Study Overview This study focuses on a new imaging agent, FG001, designed to improve the detection of oral and oropharyngeal squamous cell carcinoma (OSCC, OPSCC) during surgery. Accurate identification of cancerous tissue is crucial for better patient outcomes. Trial Details We conducted a phase II clinical trial to evaluate FG001’s effectiveness in identifying tumors. The trial involved: Participants: 16 patients undergoing surgery. Dosage: Patients received varying doses of FG001 before surgery. Monitoring: Close safety checks were performed throughout the trial. Results Key findings include: Detection Success: FG001 identified all tumors with 100%… ➡️➡️➡️

Text Messaging Versus Postal Reminders for Colorectal Cancer Screening Study Overview This study compared the effectiveness of SMS text message reminders to traditional postal reminders for increasing participation in a colorectal cancer screening program in Catalonia, Spain. Key Findings Participants: Individuals aged 50 to 69 who were invited for screening but hadn’t completed their tests. Groups: Intervention group (12,167): Received SMS reminders. Control group (12,221): Received standard postal reminders. Results: SMS group participation: 17.2%. Control group participation: 21.9%. After a second letter reminder, SMS group participation increased to 29.3%. Control group participation remained at 26.5%. Conclusions Using SMS reminders alone… ➡️➡️➡️

The Effect of Stress Ball on Anxiety and Pain Levels in Angiography: A Randomized Controlled Trial Background Coronary angiography is a procedure that can cause pain and anxiety in patients. Using stress balls as a simple tool to help reduce discomfort has not been studied much. Objective This study aims to see if using stress balls can lower pain and anxiety during angiography. Methods The study involved 120 adult patients undergoing angiography in Eastern Turkey from January to June 2023. They were randomly divided into two groups: one group used stress balls along with regular care, while the other did… ➡️➡️➡️

Cardiopulmonary Exercise Testing-Guided Exercise Therapy in Hypertensive Patients Study Overview This study looked at how exercise therapy, guided by cardiopulmonary exercise testing (CPET), affects patients with high blood pressure. It focused on improving heart and lung function, blood pressure control, and cholesterol levels. Key Findings Participants: 67 patients with Grade 1 hypertension on medication. Groups: Patients were divided into two groups: one receiving standard care and the other receiving CPET-guided exercise. Duration: The study lasted for 12 weeks without changing any medications. Results The CPET group had significantly lower blood pressure and better heart function than the conventional group. Cardiorespiratory… ➡️➡️➡️

Ultrasound Scoring in Hand Osteoarthritis Study Overview This study looked at how well the Global OMERACT/EULAR Ultrasound Synovitis Score (GLOESS) measures inflammation in hand osteoarthritis (OA) compared to just looking at synovial thickening. Key Findings Inflammation is a key target for treating hand OA. The study used data from the HOPE trial, which involved patients with painful hand OA treated with either prednisolone or a placebo. Ultrasound was used to assess 30 hand joints at different time points (weeks 0, 6, and 14). Results showed that synovial thickening was the most common finding. Both GLOESS and synovial thickening were responsive… ➡️➡️➡️

Impaired Coagulation in Early RA Improved by Antirheumatic Therapy Study Overview This study looks at how treatment affects blood clotting in patients newly diagnosed with rheumatoid arthritis (RA). Key Findings Patient Treatment: Patients started on methotrexate and were randomly assigned to receive either additional conventional treatment, certolizumab pegol, abatacept, or tocilizumab. Biomarkers Analyzed: Various blood markers related to clotting were measured at the start of treatment, and again at 12 and 24 weeks. Results Summary At the start, patients showed high levels of several clotting markers. After 24 weeks of treatment: Significant decreases were observed in F1+2, fibrinogen, D-dimer, overall… ➡️➡️➡️

Impact of Education and Behavior Change on Psoriasis Care This study explored how combining education with behavior modification affects skin care in patients with psoriasis vulgaris. Study Overview A total of 108 patients participated from November 2022 to October 2023. They were divided into two groups: Control Group: Received standard care, including medication advice and basic health education. Experimental Group: Received enhanced support, which included: Biweekly educational sessions Personalized behavior assessments Self-monitoring tools, like supervision cards Key Findings After the intervention, both groups showed improvements in: Itch Severity: Reduced itching and affected areas. Self-Efficacy: Increased confidence in managing their condition.… ➡️➡️➡️

Exploratory Testing of MRI for Renal Protection During Surgery Study Overview This study explores the use of Blood Oxygenation Level Dependent-MRI (BOLD-MRI) to measure the protective effects of Remote Ischaemic PreConditioning (RIPC) during partial nephrectomy surgery. RIPC involves temporarily restricting blood flow to the limbs to safeguard the kidneys during the procedure. Key Findings 15 patients participated in this clinical trial. RIPC was shown to significantly lower a biomarker called urinary neutrophil gelatinase-associated lipocalin (NGAL), indicating less kidney damage. NGAL levels were 65% lower in patients who received RIPC 6 hours post-surgery. BOLD-MRI showed less acute tubular damage in the… ➡️➡️➡️

Study Overview BAY 2413555 is a new treatment aimed at improving heart function in patients with heart failure (HF). This study focused on its safety, tolerability, and how the body processes it. Key Details of the Study The study was called REMOTE-HF and included multiple centers. It was a double-blind, placebo-controlled trial. Participants had HF with reduced heart function (LVEF ≤ 45%) and required specific heart devices. The study lasted over 28 days, with treatments divided into two phases. Participants and Treatment Arms Out of 129 planned participants, 22 were included: 7 in the placebo group 8 received 1.25 mg… ➡️➡️➡️

Axillary Lymph Node Dissection vs. Loco-regional Radiotherapy in Breast Cancer Treatment Background Recent years have seen major changes in how we manage the axilla (underarm area) in breast cancer treatment. The goal is to reduce surgery while still ensuring effective treatment and accurate diagnosis for patients. Advances in additional therapies have made this possible. Objective This study compares the effects of two treatments: axillary lymph node dissection (ALND) and loco-regional axillary radiotherapy (ART) on lymphedema (swelling) and disease recurrence in patients with locally advanced breast cancer (LABC) who improved after neoadjuvant chemotherapy (NACT). Methods Sixty patients with LABC, initially classified… ➡️➡️➡️

JAK Inhibition Reduces Autoimmune Issues in Down Syndrome Overview Individuals with Down syndrome (DS), caused by an extra chromosome 21, often face immune system challenges, including high autoimmunity rates and serious infections. This study explores how these immune issues relate to DS and how JAK inhibitors might help. Study Methods We conducted a detailed analysis of immune dysfunction in hundreds of people with DS. This included examining autoantibodies, cytokines, and immune cells. We also looked at the results of a Phase II clinical trial testing the JAK inhibitor tofacitinib for safety and effectiveness. Key Findings Our research revealed: Early signs… ➡️➡️➡️